Microscience Files For £40M IPO On London's AIM Index

Microscience Ltd. is looking to raise £40 million (US$71.6 million) in an initial public offering on London's Alternative Investment Market to finance development of five vaccines in clinical trials. The company is expected to have market capitalization of £120 million to £140 million.

Back to news